Affin Hwang keeps 'Hold' call on UMediC on muted earnings growth momentum (opens original article in a new tab)
Affin Hwang retains 'Hold' rating for UMediC amid limited earnings growth momentum.
- Affin Hwang maintains 'Hold' rating for UMediC
- UMediC's nine-month earnings met 71% of Affin Hwang's full-year forecast
- Earnings growth momentum is described as muted
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.